Pankaj Agarwal

Employment

• BioInfi Chief Computational Biologist
  2019 - Present
• GlaxoSmithKline USA GSK Senior Fellow, Senior Director
  1996 - 2019
• Washington University in Saint Louis Postdoctoral Research Associate
  1993 - 1996

Education

• Indian Institute of Technology Delhi B. Tech.
  1983 - 1987
• New York University Ph.D. Computer Science
  ? - 1993

Projects & Funding

Projects & funding information is unavailable.

Publications (51)

• Identification of therapeutic targets from genetic association studies using hierarchical component analysis.
  BioData mining 2020 DOI: 10.1186/s13040-020-00216-9
  +Save
• Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunities
  Drug Discovery Today 2019 DOI: 10.1016/j.drudis.2019.03.024
  +Save
• Predicting clinically promising therapeutic hypotheses using tensor factorization.
  BMC bioinformatics 2019 DOI: 10.1186/s12859-019-2664-1
  +Save
• Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease.
  PloS one 2019 DOI: 10.1371/journal.pone.0215033
  +Save
• Could advances in representation learning in Artificial Intelligence provide the new paradigm for data integration in drug discovery?
  Expert Opinion on Drug Discovery 2019 DOI: 10.1080/17460441.2019.1573811
  +Save
• Connecting genetics and gene expression data for target prioritisation and drug repositioning
  BioData Mining 2018 DOI: 10.1186/s13040-018-0171-y
  +Save
• BET Inhibition Improves NASH and Liver Fibrosis
  Scientific Reports 2018 DOI: 10.1038/s41598-018-35653-4
  +Save
• Harnessing public domain data to discover and validate therapeutic targets
  Expert Opinion on Drug Discovery 2017 DOI: 10.1080/17460441.2017.1329296
  +Save
• Trial watch: Impact of genetically supported target selection on R&D productivity.
  2016 DOI: 10.1038/nrd.2016.164
  +Save
• A High-Content Imaging Screen for Cellular Regulators of β-Catenin Protein Abundance.
  2016 DOI: 10.1177/1087057115620169
  +Save